Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III trial of bencycloquidium bromide nasal spray for cold-related nasal symptoms
ChiCTR2500107341Phase 3Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in nasopharyngitis comparing Bencycloquidium bromide nasal spray with Placebo nasal spray (2 arms). Primary endpoints: Visual analog scale for nasal symptoms and Area under the runny nose symptom severity score-time curve. Started Aug 2025; status: completed.
02
Drugs
Bencycloquidium bromide
03
Conditions
nasopharyngitis
Beyond the preview
Go deeper on ChiCTR2500107341.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500107341.